About DemyHealth Holdings
DemyHealth Holdings is a diversified healthcare, biotechnology, and diagnostics group focused on advancing molecular diagnostics, genomic medicine, biomedical engineering, research, and healthcare innovation across Nigeria and West Africa. Through its network of laboratories, research partnerships, and biotechnology subsidiaries, the group delivers advanced diagnostic testing, laboratory infrastructure solutions, sequencing services, medical devices, and life science support for hospitals, research institutions, government agencies, and private organization.
Its subsidiaries include Genecare-ng Ltd, the diagnostic services arm; Nextgen Biotech Nig Ltd, focused on laboratory equipment, consumables, diagnostic equipment, reagents, biotechnology, and laboratory solutions; and OnaPat Nig Ltd, the marketing, technology, and consultancy arm of the group.
At DemyHealth, science is not treated as routine laboratory work. It is approached with precision, responsibility, and the understanding that every result influences decisions that matter. From hospitals managing patient care to researchers advancing scientific discovery and organizations strengthening healthcare systems, our work is built around accuracy, speed, and trust.
Our strength lies in the combination of advanced molecular diagnostics, genomics, sequencing technologies, and modern laboratory infrastructure designed to meet the growing demands of healthcare and research across Africa. We do not simply process samples. We provide clinically reliable and scientifically grounded insights that support diagnosis, research, innovation, and institutional progress.
What distinguishes DemyHealth is our ability to operate at the intersection of healthcare, technology, and scientific advancement. Our laboratory systems are supported by experienced scientists, healthcare professionals, and technical experts who understand that quality is not a marketing statement. It is a standard that must be maintained at every stage of analysis, interpretation, and reporting.
Over the years, DemyHealth has contributed to large-scale diagnostic access, supported institutions with modern laboratory solutions, and delivered thousands of molecular and research projects across different sectors. Our work spans infectious disease testing, genetic analysis, oncology, sequencing services, forensic applications, biorepository services, clinical laboratory science, and advanced medical technologies.
We are built for institutions that require more than routine service. Hospitals require dependable turnaround times and diagnostic confidence. Researchers require scientific precision and advanced technology. Corporations require reliable healthcare partners capable of operating with professionalism, structure, and consistency. DemyHealth was designed to meet those expectations without compromise.
As healthcare continues to evolve, so does the need for laboratories and scientific partners that can keep pace with innovation. DemyHealth remains committed to delivering modern diagnostic and research solutions that combine global scientific standards with accessibility, operational excellence, and long-term impact across Africa.
Vision Statement
To become Africa’s leading hub for molecular diagnostics and genomic medicine, setting the standard for precision healthcare, research excellence, and public health transformation.
Mission Statement
To provide timely, accessible, affordable, and accurate diagnostic and genomic information that supports healthcare providers in diagnosing and treating patients.
To integrate cutting-edge technology with extensive specialty resources to deliver advanced molecular diagnostics, setting the pace in West Africa.
To drive innovation for improved health outcomes and scientific discovery while educating future molecular biologists, pathologists, and laboratory scientists through state-of-the-art technologies and resources.